You Do the Math!Lets make one thing clear here; we are being held back big time and extremely undervalued. Vivo is expected to report fourth-quarter revenue of over 10 million dollars; yet, we have a market cap of about 270 million dollars. As per the reading below; Cronos will report just over one million dollars for Q4 with a market cap of almost 5 billion dollars; Tilray will report about 12 million dollars Q4 and have over 7 billion dollar market cap. These are facts and it doesn't take a genius to know that Vivo is going to pop and get its true value real soon ($4.00 plus a share). Tilray is knocking on their door and it would not suprise me, if they are putting the pen to the paper. Good times ahead. GLTA!
Cronos Group
Cronos Group is expected to post its fourth-quarter results Feb. 22, although it has not been officially confirmed. The results will compare with a revenue of $1.02 million posted for the same quarter of fiscal 2018 and $2.85 million reported for last quarter. For the third quarter, Cronos posted a net loss of 3 cents per share.
In December, Cronos received a major investment from the Altria Group Inc (NYSE: MO), which acquired a 45-percent stake in the company.
Tilray
Tilray should also file its fourth-quarter earnings report Feb. 22. Analysts expect the cannabis producer to report revenue of $12.83 million, versus the previous quarter's result of $10 million. The bottom-line consensus estimate is for a loss of 14 cents, narrower than the loss of 20 cents a quarter earlier.
Read more at https://stockhouse.com/news/press-releases/2019/02/07/what-to-expect-from-cannabis-stocks-this-earnings-season#fYoq5cXJcFrQzTVx.99